CXF vs. FRX, APM, IPA, GXE, ITH, CRDL, GPH, MDNA, EQ, and WMD
Should you be buying CI Canadian Convertible Bond ETF Common stock or one of its competitors? The main competitors of CI Canadian Convertible Bond ETF Common include Fennec Pharmaceuticals (FRX), Andean Precious Metals (APM), ImmunoPrecise Antibodies (IPA), Gear Energy (GXE), International Tower Hill Mines (ITH), Cardiol Therapeutics (CRDL), Graphite One (GPH), Medicenna Therapeutics (MDNA), EQ (EQ), and WeedMD (WMD). These companies are all part of the "pharmaceutical products" industry.
CI Canadian Convertible Bond ETF Common vs.
Fennec Pharmaceuticals (TSE:FRX) and CI Canadian Convertible Bond ETF Common (TSE:CXF) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, community ranking, analyst recommendations, valuation and institutional ownership.
Fennec Pharmaceuticals has a net margin of 5.59% compared to CI Canadian Convertible Bond ETF Common's net margin of 0.00%. CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Fennec Pharmaceuticals' return on equity.
52.8% of Fennec Pharmaceuticals shares are owned by institutional investors. 16.2% of Fennec Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
In the previous week, Fennec Pharmaceuticals' average media sentiment score of 0.00 equaled CI Canadian Convertible Bond ETF Common'saverage media sentiment score.
Fennec Pharmaceuticals received 93 more outperform votes than CI Canadian Convertible Bond ETF Common when rated by MarketBeat users. Likewise, 69.80% of users gave Fennec Pharmaceuticals an outperform vote while only 57.89% of users gave CI Canadian Convertible Bond ETF Common an outperform vote.
Fennec Pharmaceuticals has higher revenue and earnings than CI Canadian Convertible Bond ETF Common.
Summary
Fennec Pharmaceuticals beats CI Canadian Convertible Bond ETF Common on 9 of the 10 factors compared between the two stocks.
Get CI Canadian Convertible Bond ETF Common News Delivered to You Automatically
Sign up to receive the latest news and ratings for CXF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CI Canadian Convertible Bond ETF Common Competitors List
Related Companies and Tools
This page (TSE:CXF) was last updated on 1/21/2025 by MarketBeat.com Staff
Free CXF Stock Alerts